Omnicell Inc
$ 41.00
2.86%
24 Jul - close price
- Market Cap 1,864,635,000 USD
- Current Price $ 41.00
- High / Low $ 41.10 / 39.97
- Stock P/E 93.18
- Book Value 27.63
- EPS 0.44
- Next Earning Report 2026-07-30
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.01 %
- ROE 0.02 %
- 52 Week High 55.00
- 52 Week Low 28.51
About
Omnicell, Inc., provides medication management automation solutions and adherence tools for health care systems and pharmacies in the United States and internationally. The company is headquartered in Mountain View, California.
Analyst Target Price
$61.29
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-28 | 2026-02-05 | 2025-10-30 | 2025-07-31 | 2025-05-06 | 2025-02-06 | 2024-10-30 | 2024-08-01 | 2024-05-02 | 2024-02-08 | 2023-11-02 | 2023-08-01 |
| Reported EPS | 0.55 | 0.4 | 0.51 | 0.45 | 0.26 | 0.6 | 0.56 | 0.51 | 0.03 | 0.33 | 0.62 | 0.57 |
| Estimated EPS | 0.33 | 0.5 | 0.36 | 0.27 | 0.2 | 0.58 | 0.42 | 0.14 | -0.09 | 0.15 | 0.48 | 0.28 |
| Surprise | 0.22 | -0.1 | 0.15 | 0.18 | 0.06 | 0.02 | 0.14 | 0.37 | 0.12 | 0.18 | 0.14 | 0.29 |
| Surprise Percentage | 66.6667% | -20% | 41.6667% | 66.6667% | 30% | 3.4483% | 33.3333% | 264.2857% | 133.3333% | 120% | 29.1667% | 103.5714% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-30 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 0.31 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: OMCL
2026-07-27 05:12:08
Omnicell Inc (OMCL) currently has an earnings forecast score of 8.00, placing it 68th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $47.00, with a majority recommending a "Buy" trend for the stock. The company's expected revenue for the next quarter is $310.25 million, and its EPS for the upcoming quarter is projected at $0.47.
2026-07-25 08:41:14
This article provides a valuation analysis of Omnicell Inc (OMCL), noting its current valuation score of 6.66, ranking 178 out of 200 in the Healthcare Equipment & Supplies industry. The company's P/E ratio stands at 91.94, which is significantly below its recent high but above its recent low. Key valuation metrics like P/B, P/S, and P/CF have not been disclosed by the company.
2026-07-24 15:12:09
This article provides an overview of Omnicell Inc (OMCL) stock, including its current trading price, market capitalization, and P/E ratio. It specifically addresses the company's dividend history, noting that no dividends have been distributed over the past five years. The page indicates there is no dividend data available for Omnicell Inc.
2026-07-24 13:12:08
Omnicell Inc. (OMCL) is a provider of medication management solutions and adherence tools for health systems and pharmacies, focusing on transforming pharmacy care through innovation. The company's solutions utilize robotics, smart devices, intelligent software, and services to optimize clinical and business outcomes. Omnicell's offerings include point-of-care automation solutions like the XT Series automated dispensing systems designed for various healthcare settings.
2026-07-24 04:12:08
This article provides key financial data for Omnicell, Inc. (BX:OC9), specifically focusing on its "Price to earnings forward" metric. It details where this financial information is sourced from and highlights that the market was closed at the time of publication, with no trades having occurred.
2026-07-23 17:41:00
This article provides the "Price to book forward" financial metric for Omnicell, Inc. (NASDAQ: OMCL). The content is primarily a data page from TradingView, displaying the specific financial value along with the period, change, and percentage change.
